Stockscreener 앱 받기
144.24
0.05%
0.06
전일 마감가:
$144.18
열려 있는:
$145.19
하루 거래량:
1.38M
Relative Volume:
0.49
시가총액:
$39.77B
수익:
$21.37B
순이익/손실:
$1.41B
주가수익비율:
36.57
EPS:
3.9437
순현금흐름:
$3.07B
1주 성능:
-5.88%
1개월 성능:
-7.37%
6개월 성능:
-25.28%
1년 성능:
-15.66%
1일 변동 폭
$143.64
$146.24
1주일 범위
$142.83
$155.28
52주 변동 폭
$142.83
$213.08
벡톤 디킨슨 Stock (BDX) Company Profile
명칭
Becton Dickinson Co
전화
(201) 847-6800
주소
ONE BECTON DR, FRANKLIN LAKES
Compare BDX vs ISRG, MDLN, ALC, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BDX
Becton Dickinson Co
|
144.35 | 39.73B | 21.37B | 1.41B | 3.07B | 3.9437 |
ISRG
Intuitive Surgical Inc
|
427.27 | 153.09B | 10.58B | 3.00B | 2.83B | 8.2437 |
MDLN
Medline Inc
|
38.89 | 32.73B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
63.81 | 30.94B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
202.51 | 29.36B | 5.54B | 1.52B | 1.74B | 10.37 |
벡톤 디킨슨 Stock (BDX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-10 | 재개 | Goldman | Neutral |
| 2026-02-10 | 재개 | Barclays | Overweight |
| 2026-02-03 | 재개 | Citigroup | Buy |
| 2025-09-25 | 개시 | RBC Capital Mkts | Sector Perform |
| 2025-05-22 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-05-02 | 다운그레이드 | Goldman | Buy → Neutral |
| 2025-05-02 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2025-05-02 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2025-05-01 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-05-01 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2025-05-01 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2024-10-01 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2023-07-24 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2023-05-30 | 재개 | Morgan Stanley | Overweight |
| 2023-05-05 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-04-12 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-01-03 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-12-12 | 업그레이드 | Citigroup | Sell → Neutral |
| 2022-07-11 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2022-06-24 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-03-18 | 재개 | Raymond James | Mkt Perform |
| 2022-03-02 | 재개 | BofA Securities | Neutral |
| 2021-12-08 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-08-06 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-05-25 | 개시 | Barclays | Equal Weight |
| 2020-12-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-12-15 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-07-09 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2020-06-01 | 재개 | Goldman | Buy |
| 2020-03-05 | 개시 | Citigroup | Neutral |
| 2020-02-07 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2020-02-07 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-07 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2020-02-06 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2020-01-08 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2019-05-13 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2018-12-07 | 개시 | Deutsche Bank | Buy |
| 2018-10-16 | 개시 | Barclays | Equal Weight |
| 2018-06-21 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-04-10 | 업그레이드 | Citigroup | Neutral → Buy |
| 2018-01-19 | 재개 | BofA/Merrill | Buy |
| 2018-01-05 | 업그레이드 | Citigroup | Sell → Neutral |
| 2018-01-05 | 개시 | KeyBanc Capital Mkts | Overweight |
| 2018-01-03 | 개시 | Evercore ISI | Outperform |
| 2017-12-29 | 재확인 | Deutsche Bank | Buy |
모두보기
벡톤 디킨슨 주식(BDX)의 최신 뉴스
Global Cervical Cancer Diagnostics Market to Exhibit Growth at a CAGR of ~5% by 2034 | DelveInsight - GlobeNewswire Inc.
Becton Dickinson & Co. stock underperforms Wednesday when compared to competitors - MarketWatch
Becton, Dickinson and Company (BDX) Announces €600 Million Euro Notes Offering - GuruFocus
Becton Dickinson & Co (BDX) News Flow - Moomoo
Becton Dickinson & Co. stock outperforms competitors on strong trading day - MarketWatch
Becton Dickinson launches €600M euro-note offering to refinance 2026 notes - TradingView
This Becton Dickinson Insider Increased Their Holding In The Last Year - Moomoo
Is Becton Dickinson & Co (BDX) a Bargain After 4.2% Drop? GF Val - GuruFocus
Becton Dickinson & Co. stock underperforms Monday when compared to competitors - MarketWatch
BD appoints Vitor Roque as permanent CFO - MedTech Dive
Dental Needle Market Is Going to Boom |• BD (Becton Dickinson and Company) • Terumo Corporation - openPR.com
Barclays Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Maintains Target Price $204 - Moomoo
Jim Cramer on Becton, Dickinson: “The Company Showed Excellent Execution Across the Board” - Insider Monkey
Becton, Dickinson and Company Q2 Earnings Call Highlights - sharewise.com
4: Statement of changes in beneficial ownership of securities - Becton Dickinson
Becton Dickinson & Co. stock outperforms competitors despite losses on the day - MarketWatch
Becton, Dickinson Building Growth After 'Clean' Fiscal Q2 Beat, RBC Says - Moomoo
RBC Capital Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Maintains Target Price $175 - 富途牛牛
Becton, Dickinson and Company (NYSE:BDX) Q2 2026 Earnings Call Transcript - Insider Monkey
Pregnancy Detection Kits Market Analysis Report 2026 - GlobeNewswire Inc.
Research Alert: CFRA Maintains Hold Rating On Shares Of Becton, Dickinson And Company - Moomoo
Update: Becton, Dickinson Shares Rise After Higher Fiscal Q2 Results; Vitor Roque Named as CFO - Moomoo
Becton Dickinson Lifts EPS Outlook Amid Mixed Headwinds - TipRanks
Evercore ISI Adjusts Price Target on Becton, Dickinson and Company to $190 From $180 - Moomoo
Becton Dickinson hikes profit outlook, names CFO - MSN
Is the options market predicting a spike in Becton Dickinson stock? - MSN
Why Is Becton Dickinson Stock Gaining Thursday?Becton Dickinson (NYSE:BDX) - Benzinga
Becton Dickinson & Co(BDX) Stock Options Chain | Quotes & News - Moomoo
Deals tracker: Cross Country Healthcare to be acquired for $437M - Modern Healthcare News
Becton Dickinson Q2 FY26 slides: EPS beat drives guidance raise - Investing.com
TD Cowen Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Maintains Target Price $163 - Moomoo
Earnings call transcript: Becton Dickinson Q2 2026 beats earnings expectations By Investing.com - Investing.com Australia
Earnings call transcript: Becton Dickinson Q2 2026 beats earnings expectations - Investing.com
Q2 2026 Becton Dickinson and Co Earnings Call Transcript - GuruFocus
Research Alert: Becton Dickinson Tops Q1 Estimates, Bumps Forward Guidance - Moomoo
Becton Dickinson (BDX) Q2 Earnings and Revenues Surpass Estimates - Yahoo Finance UK
Becton Dickinson stock gains after company lifts earnings outlook By Investing.com - Investing.com South Africa
BDX (Becton Dickinson) Posts EPS Beat in Q2 2026, Pre-Market Rallies Despite Slight Revenue Miss - ChartMill
Becton Dickinson Raises Earnings Guidance, Interventional Growth Boosts Revenue - Moomoo
Becton Dickinson stock gains after company lifts earnings outlook - Investing.com
Becton Dickinson: Fiscal Q2 Earnings Snapshot - KING5.com
Becton Dickinson Had Seen FY26 Adjusted EPS $12.35-$12.65 >BDX - Moomoo
BD Appoints Vitor Roque Chief Financial Officer – Company Announcement - Financial Times
BDX Stock Price, Quote & Chart | BECTON DICKINSON AND CO (NYSE:BDX) - ChartMill
MSN Money - MSN
Becton Dickinson earnings loom as investors eye post-divestiture growth By Investing.com - Investing.com
INVESCO V.I. EQUITY AND INCOME FUND's Becton Dickinson & Co(BDX) Holding History - GuruFocus
Becton Dickinson & Co. stock underperforms Tuesday when compared to competitors - MarketWatch
Becton Dickinson (BDX) Receives Outperform Rating with $180 Pric - GuruFocus
TD Cowen Adjusts Price Target on Becton, Dickinson and Company to $163 From $189, Maintains Hold Rating - Moomoo
Evercore Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Cuts Target Price to $180 - 富途牛牛
벡톤 디킨슨 (BDX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.26%
1.59%
자본화:
|
볼륨(24시간):